Hourly News Update
Tag Archives: progression-free survival
By Caitlin Sinett on September 27th, 2013 | Last updated: September 27, 2013 at 3:41 pm
A new drug that extends thyroid cancer patients’ survival periods is under FDA review to be completed by Dec. 25. Nexavar does not completely stop the cancer, but it does slow the growth and overall progression.